Beurs.nl monitor iconMarkt Monitor
  • AEX -7,22 907,46 -0,79%
  • DE40 0,00 22.678,74 0,00%
  • US500^ -117,04 5.576,54 -2,06%
  • US30^ -754,90 41.559,60 -1,78%
  • EUR/USD +0,00 1,0826 +0,27%
  • WTI -0,79 69,15 -1,13%
  • Gold spot +25,57 3.080,58 +0,84%

Op naar 1 euro

15.953 Posts
Pagina: «« 1 ... 241 242 243 244 245 ... 798 »» | Laatste | Omlaag ↓
  1. [verwijderd] 9 november 2015 13:10
    quote:

    $euri schreef op 9 november 2015 13:08:

    Om een of andere reden wil men ze dus wel hebben, gezien de bied
    Precies, dus mogelijk toch iets te maken met gisteren :)
  2. [verwijderd] 9 november 2015 13:27
    quote:

    Blijvenhopen schreef op 9 november 2015 13:26:

    Doe niet zo naief..de kleinste schommeling kan al 2procent teweeg brengen
    Dit verandert per minuut.
    je hebt optimisten en pesimisten
  3. [verwijderd] 9 november 2015 14:43
    quote:

    $euri schreef op 9 november 2015 14:25:

    Hilarisch die euforie over een paar honderdste cent
    Beter zo dan elkaar steeds te lopen afzijken.
  4. [verwijderd] 9 november 2015 14:47

    By Lauren Pollock
    Valeant Pharmaceuticals International Inc. said it would provide a business update during a conference call on Tuesday morning.
    The pharmaceutical company's shares have tumbled in recent weeks amid questions about its drug pricing, business and accounting practices. The company has said it has found no evidence of illegality but established a board committee to look into its relationship with a specialty pharmacy that distributed its drugs.
    Chief Executive J. Michael Pearson, along with Chief Financial Officer Robert Rosiello and other executives, will take part in the call at 8 a.m. ET.
    The company plans to offer an overview of current plans and priorities, including the transition plan from specialty pharmacy Philidor. There will also be a question and answer segment for investors and analysts.
    Valeant has previously said Mr. Pearson has the full confidence of its board. William Ackman, one of Valeant's largest shareholders, has also expressed faith in Mr. Pearson but said last week that the board has assured him it is considering any and all alternatives that would benefit shareholders, which could be viewed as an indication the CEO should be prepared to step down or sell the company if more extreme steps become necessary.
    Valeant added it intends to host an investor day and update its annual and quarterly financial guidance before the end of the year.
    Write to Lauren Pollock at lauren.pollock@wsj.com
    Subscribe to WSJ: online.wsj.com?mod=djnwires
    (END) Dow Jones Newswires
    November 09, 2015 08:37 ET (13:37 GMT)
    © 2015 Dow Jones & Company, Inc.

    AAND VALEANT PHARMA INTERN AM NOT
    CA91911K1021
  5. [verwijderd] 9 november 2015 14:52
    Het is zo onvoorstelbaar dom idd,die koerst schiet per seconde van ruim 2 peocent naar 1 procent en iedereen wordt blij.Einde van de dag staat het gewoon weer in het rood zoals iedere dag.Wat heb je er dan aan als het paar minuten in het groen heeft gestaan?puur optisch
15.953 Posts
Pagina: «« 1 ... 241 242 243 244 245 ... 798 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beurs.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.119
AB InBev 2 5.538
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.173
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.857
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.839
Aedifica 3 926
Aegon 3.258 323.075
AFC Ajax 538 7.089
Affimed NV 2 6.305
ageas 5.844 109.905
Agfa-Gevaert 14 2.063
Ahold 3.538 74.353
Air France - KLM 1.025 35.290
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.050
Alfen 16 25.276
Allfunds Group 4 1.517
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 420
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.901
AMG 971 134.353
AMS 3 73
Amsterdam Commodities 305 6.745
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 496
Antonov 22.632 153.605
Aperam 92 15.056
Apollo Alternative Assets 1 17
Apple 5 386
Arcadis 252 8.806
Arcelor Mittal 2.034 320.983
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.352
Aroundtown SA 1 221
Arrowhead Research 5 9.751
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.614
ASML 1.766 110.152
ASR Nederland 21 4.512
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.937
Axsome Therapeutics 1 177
Azelis Group 1 67
Azerion 7 3.449